Author Archives: Greg Cantin, PhD

Microbial Strain Development Using BioLayer Interferometry

At the core of every drug development program is the challenge to successfully express active and high-quality proteins. Drug developers often are faced with protein-expression issues, struggling to express a specific protein for months (and sometimes years) with varying degrees of success. Low or no expression, insoluble expression, and proteolytic clipping of an expressed protein or a combination thereof are examples of the hurdles encountered in product development efforts. With protein expression being vital to the success of every stage…